Research ArticleCANCER IMMUNOLOGY

KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target

See allHide authors and affiliations

Science Immunology  09 Jul 2021:
Vol. 6, Issue 61, eabf9792
DOI: 10.1126/sciimmunol.abf9792

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Immunology